Most Viewed Posts Clear Filters Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested 2 February 2018 The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis 6 June 2018 Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model 25 January 2019 Clear Filters Alzheimer22 August 2026 REGEnLIFE: a new step towards a practical and accessible treatment to address the public health challenges posed by Alzheimer’s disease. Alzheimer22 August 2026 Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes Alzheimer22 August 2026 Regenlife opens a clinical research centre at Biofortis in Nantes to study Alzheimer’s disease Past Events22 August 2026 REGEnLIFE Appoints Dr. Volker Herrmann as CEO to accelerate corporate growth and global expansion Alzheimer28 May 2026 Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease
